bio pharma

Switzerland, a Hub for Pharma/Bio-Pharma Open Innovation

An opportunity for Korean pharmaceutical and biopharma companies to be one step closer to entering European market

Find out why Switzerland is a world leading hub for open innovation and R&D cooperation for pharma/bio-pharma industry. 

Switzerland is a world leading innovation hub for pharma/bio-pharma industry.  As a home for top-tier global pharmaceutical companies including Norvatis and Roche, Switzerland has achieved continuous innovation through open innovation among research/medical institutions, global companies and start-ups for a long time.

Highly developed infrastructure, talented workforce in pharma/bio-pharma sector and the A to Z value chain across the industry provide an ideal ecosystem for foreign pharma/bio companies to conduct activities like strategic partnership, licensing in/out, and patent transaction. 

The core advantages of Swiss life science cluster are; 1) Innovative R&D collaboration opportunity with global pharma/bio-pharma companies and startups 2) Life science specialized talents, 3) Stable environment nurturing globally successful start-ups.

If you are currently planning to expand your business into Europe and consider Switzerland as a new business location or innovative open innovation R&D partner, please register for our webinar. We hope that this webinar provides an opportunity for Korean pharmaceutical and biopharma companies to be one step closer to entering European market. 



Zielpublikum Korean companies planning to expand into European market and/or seek R&D open innovation with Switzerland (C-level and manager level recommended)
Veranstalter Swiss Business Hub Korea, Switzerland Innovation




ZOOM link to be provided after RSVP.  This webinar is to be recorded for internal use only


Online (Korean Standard Time / Simultaneous interpretation will be provided.)



Opening Speech

by Dr. Roger Zbinden, Head, Swiss Business Hub Korea

Welcome Remarks

by Dr. Hee-Mok Won, Chairman, Korea Pharmaceutical and Bio-Pharma Manufacturers Association

Switzerland Innovation and the Swiss Innovation Ecosystem

by Raymond Cron, CEO, Switzerland Innovation

Open Innovation in the Basel Area: BioCampus Initiative

by Maarten van Winckel, Innovation & Entrepreneurship, University of Basel

Future of Pharma Production

by Ian Marison, CEO, BioFactory Competence Center, Fribourg

Strategies for a successful cooperation with Swiss academia – examples EPFL and ETH

by Robert Giezendanner-Thoben, Head, Business Development, EPFL and Dr. Urs Zuber, Head, Industry Relations, ETH



Contact information

Swiss Business Hub Korea  02-3704-4776  seoul.sbhkorea@eda.admin.ch   

TICA Company 010-2222-7387  ticacompany2@gmail.com 


Official program